Hypertriglyceridemia, insulin resistance, and the metabolic syndrome.

[1]  S. Dinneen,et al.  HIV Testing in Pregnant Women , 1998, Annals of Internal Medicine.

[2]  T. Wadden,et al.  Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance. , 1998, Archives of internal medicine.

[3]  A. Bonen,et al.  Glucose tolerance is improved after low- and high-intensity exercise in middle-age men and women. , 1998, Canadian Journal of Applied Physiology.

[4]  A. Goldberg,et al.  Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men. , 1998, Metabolism: clinical and experimental.

[5]  C. Spurr,et al.  Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with Troglitazone , 1998, Annals of Internal Medicine.

[6]  B. Neuschwander‐Tetri,et al.  Troglitazone-Induced Hepatic Failure Leading to Liver Transplantation: A Case Report , 1998, Annals of Internal Medicine.

[7]  E. Kraegen,et al.  The Determinants of Glycemic Responses to Diet Restriction and Weight Loss in Obesity and NIDDM , 1998, Diabetes Care.

[8]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[9]  Grundy,et al.  Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue , 1998, Journal of internal medicine.

[10]  R N Bergman,et al.  Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. , 1998, JAMA.

[11]  S. Grundy.  Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. , 1998, The American journal of cardiology.

[12]  L. Goodyear,et al.  Exercise, glucose transport, and insulin sensitivity. , 1998, Annual review of medicine.

[13]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .

[14]  A. Hamsten,et al.  Plasminogen Activator Inhibitor-1 Gene Implicated in the Impaired Fibrinolysis of Very-low-density Lipoprotein Response Element in the Promoter Region of the Human , 2022 .

[15]  J. Hagberg,et al.  Improvement of insulin sensitivity by short-term exercise training in hypertensive African American women. , 1997, Hypertension.

[16]  A. Dunaif,et al.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.

[17]  M. Alessi,et al.  PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events , 1997, Thrombosis and Haemostasis.

[18]  C. Wilson,et al.  Exercise training reverses insulin resistance in muscle by enhanced recruitment of GLUT-4 to the cell surface. , 1997, The American journal of physiology.

[19]  M. Zamboni,et al.  The benefits of modest weight loss in type II diabetes. , 1997, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[20]  S M Grundy,et al.  Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. , 1997, Circulation.

[21]  B. Walker.  Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease. , 1996, Endocrine research.

[22]  M. Shimada,et al.  Hypertriglyceridemia, but not Hypercholesterolemia, is Associated with the Alterations of Fibrinolytic System , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[23]  D L Rothman,et al.  Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. , 1996, The New England journal of medicine.

[24]  S. Hunt,et al.  Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? , 1996, Current opinion in lipidology.

[25]  A. Goldberg,et al.  Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men , 1996 .

[26]  M. Austin,et al.  Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes , 1996, Current opinion in lipidology.

[27]  N. Hirawa,et al.  Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity. , 1996, Hypertension.

[28]  K. Asplund,et al.  Insulin resistance syndrome and fibrinolytic activity: the northern Sweden MONICA study. , 1996, International journal of epidemiology.

[29]  G. Reaven,et al.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.

[30]  A. Goldberg,et al.  Weight loss reduces abdominal fat and improves insulin action in middle-aged and older men with impaired glucose tolerance. , 1995, Metabolism: clinical and experimental.

[31]  S. Kahn,et al.  Changes in insulin sensitivity, glucose effectiveness, and B-cell function in regularly exercising subjects. , 1995, Metabolism: clinical and experimental.

[32]  G. Reaven,et al.  Pathophysiology of insulin resistance in human disease. , 1995, Physiological reviews.

[33]  D. Raccah,et al.  Hypofibrinolysis and the insulin resistance syndrome. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[34]  Y. Hata,et al.  Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1. , 1995, Journal of atherosclerosis and thrombosis.

[35]  I. Godsland.  Insulin resistance in hypertension , 1994, The Lancet.

[36]  G. Miller.  Lipoproteins and the haemostatic system in atherothrombotic disorders. , 1994, Bailliere's clinical haematology.

[37]  R. Bergman,et al.  Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[38]  S. Grundy,et al.  Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. , 1994, JAMA.

[39]  M. Laakso,et al.  Isolated Low HDL Cholesterol: An Insulin-Resistant State , 1994, Diabetes.

[40]  G. Steiner.  Hyperinsulinaemia and hypertriglyceridaemia. , 1994, Journal of internal medicine. Supplement.

[41]  J. Sowers,et al.  Insulin Resistance in Hypertension: A Focused Review , 1993, The American journal of the medical sciences.

[42]  M. Blankenstein,et al.  The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. , 1993, Metabolism: clinical and experimental.

[43]  V. Armstrong,et al.  Investigations into the haemorheological significance of postprandial and fasting hypertriglyceridaemia , 1993, European journal of clinical investigation.

[44]  J S Yudkin,et al.  Impaired glucose tolerance. , 1990, BMJ.

[45]  L. Wilhelmsen,et al.  Metabolic disturbances in hypertension: results from the population study ‘ Men born in 1913’ , 1992, Journal of internal medicine.

[46]  S. Hunt,et al.  Familial dyslipidaemic hypertension and other multiple metabolic syndromes. , 1992, Annals of medicine.

[47]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[48]  J. Sowers.  Insulin resistance and hypertension , 1990, Molecular and Cellular Endocrinology.

[49]  S. Grundy,et al.  Management of Primary Mixed Hyperlipidemia With Lovastatin , 1990 .

[50]  R. Campbell,et al.  Coronary heart disease in high-risk populations: lessons from Finland. , 1990, European heart journal.

[51]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[52]  J. Huttunen,et al.  Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study. , 1989, The American journal of cardiology.

[53]  M. Jensen,et al.  Influence of body fat distribution on free fatty acid metabolism in obesity. , 1989, The Journal of clinical investigation.

[54]  D. V. Dale.  Diet and exercise in the treatment of obesity , 1989 .

[55]  G. Rosenhamer,et al.  Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. , 2009, Acta medica Scandinavica.

[56]  S. Hunt,et al.  Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. , 1988, JAMA.

[57]  R. Norum,et al.  Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. , 1986, The Journal of clinical investigation.

[58]  R. Havel,et al.  Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. , 1985, Journal of lipid research.

[59]  K. Minaker,et al.  Characterization of the insulin resistance of aging. , 1983, The Journal of clinical investigation.